LONDON, 22 July 2021 - DeepMind today announced its partnership with the European Molecular Biology Laboratory (EMBL), Europe's flagship laboratory for the life sciences, to make the most complete and ...

On July 22, a historic milestone in artificial intelligence (AI) and biotechnology was achieved. U.K.-based DeepMind, a wholly owned subsidiary of Google-parent Alphabet Inc., and the European ...

Researchers will have free access to chemogenomic databases developed by Galapagos under a €1.8 million licensing agreement between the Belgian drug discovery company and the European Molecular ...

As part of the Nordic EMBL Partnership for Molecular Medicine, outstanding doctoral researchers are recruited to the institute-level rotation programme through the annual call. The recruited doctoral ...

DeepMind is partnering with EMBL to make the most complete and accurate database yet of the predicted human protein structures freely and openly available to the scientific community. The AlphaFold ...

LONDON, July 26, 2021 — DeepMind announced its partnership with the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory for the life sciences, to make the most complete and ...